Athero Review - Issue 3/2020
Editorial
141
Editorial
Michal Vrablík
Guidelines
147
Genetic testing of familial hypercholesterolemia in clinical practice: statement of Czech Society for Atherosclerosis
Michal Vrablík, Vladimír Bláha, Renata Cífková, Tomáš Freiberger, David Karásek, Pavel Kraml, Jan Piťha, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Lukáš Tichý, Zuzana Urbanová Za Výbor Čsat, Jana Mašková
Reviews
158
Impact of SGLT2 inhibitors and real clinical practice
Branislav Vohnout, Jana Lisičanová, Andrea Havranová
163
Hypertriglyceridemia – today and tomorrow
Martin Šatný, Michal Vrablík
168
Selected biomarkers associated with atherosclerosis and bone metabolism
Katarína Demková, Ivan Tkáč
173
Patient variability in nutritional case reports
Věra Boháčová, Tamara Starnovská
Clinical Studies
176
185
LIPIcontrol 2 what has changed after 3 years
Martin Šatný, Michal Vrablík
197
A little change in payment means a big chance for a lot of ills
Lucie Ondřichová
From scholarly literature
200
Personal News
202
Professor Rudolf Poledne eighty-year old
Jan Piťha
Annoucements
203
Athero Review
2020 Issue 3
Most read in this issue
- Hypertriglyceridemia – today and tomorrow
- Genetic testing of familial hypercholesterolemia in clinical practice: statement of Czech Society for Atherosclerosis
- GLP-1 receptor agonists: antidiabetic agents with antiatherogenic effect
- Mendelian randomisation studies: principle and selected examples from cardiovascular medicine